ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ANVS

Annovis Bio (ANVS)

Annovis Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:ANVS
DateTimeSourceHeadlineSymbolCompany
02/27/20248:00AMGlobeNewswire Inc.Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024AMEX:ANVSAnnovis Bio Inc
02/14/20247:30AMGlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s DiseaseAMEX:ANVSAnnovis Bio Inc
01/30/20248:00AMGlobeNewswire Inc.Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company’s PortfolioAMEX:ANVSAnnovis Bio Inc
01/24/20248:00AMGlobeNewswire Inc.Annovis Bio Refines Timeline for Parkinson’s Phase III Study Data AnnouncementAMEX:ANVSAnnovis Bio Inc
12/11/20231:00PMGlobeNewswire Inc.Annovis Bio to Participate in the 139th Yale CEO SummitAMEX:ANVSAnnovis Bio Inc
12/05/20237:30AMGlobeNewswire Inc.Annovis Bio Announces Last Patient Last Visit in the Phase III Study of Buntanetap in Parkinson’s DiseaseAMEX:ANVSAnnovis Bio Inc
12/01/20237:30AMGlobeNewswire Inc.Annovis Bio Appoints Andrew Walsh as Vice President FinanceAMEX:ANVSAnnovis Bio Inc
11/27/20237:30AMGlobeNewswire Inc.Annovis Bio Announces Full Enrollment of Its Phase II/III Alzheimer’s Disease Trial, Exceeding Original ProjectionsAMEX:ANVSAnnovis Bio Inc
11/08/20235:00PMGlobeNewswire Inc.Annovis Bio Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateAMEX:ANVSAnnovis Bio Inc
10/12/20238:02AMGlobeNewswire Inc.Annovis Bio Announces Positive Interim Independent Analysis for Statistical Power in Its Alzheimer’s StudyAMEX:ANVSAnnovis Bio Inc
06/16/20234:19PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
05/30/20235:20PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
05/10/20234:35PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
04/28/20238:01AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:ANVSAnnovis Bio Inc
04/26/20234:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
04/25/20236:01AMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:ANVSAnnovis Bio Inc
04/03/20235:29PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
04/03/20237:53AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
03/31/20239:19AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
02/08/20235:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/20/20235:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANVSAnnovis Bio Inc
01/06/20234:06PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
11/08/20224:45PMEdgar (US Regulatory)Quarterly Report (10-q)AMEX:ANVSAnnovis Bio Inc
09/12/20225:10PMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
08/30/20226:05AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
08/08/20228:31AMEdgar (US Regulatory)Current Report Filing (8-k)AMEX:ANVSAnnovis Bio Inc
 Showing the most relevant articles for your search:AMEX:ANVS
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com